Germany· DE-A57-d422d860fbcb36e2
Aprepitant Hexal
A aprepitant product containing aprepitant, registered in Germany by Hexal Ag. The same ATC class is registered in 17 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Aprepitant is registered in 17 of 19 countries.
Countries holding a registration under ATC A04AD12 (aprepitant), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Aprepitant · ATC A04AD12
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of aprepitant costs, country by country.
Normalised to the WHO defined daily dose (165 mg), the median price runs from $0.40 in Finland to $157.48 in United States — a ×394 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Aprepitant · price per daily dose (165 mg)
USD · FX 28 Sept 2026
- US United States$157.48 (acquisition cost)
- CH Switzerland$73.26
- FR France$33.15
- FI Finland$0.40
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Aprepitant
- Manufacturer
- Hexal Ag
- Country
- Germany (DE)
- ATC code
- A04AD12
- ATC class
- Aprepitant
- Defined daily dose
- 165 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
583 interactions on record for aprepitant.
Graded by severity as the source publishes them — 73 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aprepitant · interactions on record
583 records
- 73 severe
- 380 moderate
- 25 minor
- 104 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- EliglustatA16AX10severe
- LonafarnibA16AX20severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aprepitant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAprepitant Accord 125 mg harde capsulesAccord Healthcare B.V.
- United KingdomAprepitant 125mg capsulesMartindale Pharmaceuticals Ltd
- FranceAPREPITANT ACCORD 125 mg et APREPITANT ACCORD 80 mg, géluleACCORD HEALTHCARE FRANCE
- United StatesAPONVIEHeron Therapeutics, Inc.
- IcelandAprepitant Medical ValleyMedical Valley Invest AB
- SpainAPREPITANT ACCORD 125 MG CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- SwedenAprepitant Ebb 125 mg + 80 mg Kapsel, hårdEbb Medical AB
- BelgiumAprepitant Sandoz 125 mg - 80 mgSandoz
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Aprepitant Accord, Aprepitant Ratiopharm
- Belgium · Aprepitant Sandoz, Aprepitant Teva
- Cyprus · Atanto, Endrem
- Czechia · Aprepitant Accord, Aprepitant Sandoz
- Denmark · Aprepitant "medical Valley", Aprepitant Medical Valley
- Estonia · Aprepitant Sandoz
- Spain · Aprepitant Accord, Aprepitant Qilu
- Finland · Aprepitant Stada
- France · Aprepitant Accord, Aprepitant Aprepitant
- United Kingdom (Northern Ireland) · Aprepitant, Aprepitant Accord
- Greece · Aprepitant Win Medica, Atanto
- Croatia · Aprepitant Alpha-Medical, Aprepitant Sandoz
- Hungary · Aprepitant Pharmacenter, Aprepitant Q Pharma
- Ireland · Aprepitant Accord
- Iceland · Aprepitant Medical Valley, Aprepitant Stada
- Italy · Aprepitant Accord, Aprepitant Teva
- Liechtenstein · Emend
- Lithuania · Aprepitant Sandoz
- Latvia · Aprepitant Sandoz
- Netherlands · Aprepitant Accord, Aprepitant Aurobind
- Norway · Emend
- Poland · Aprepitant Accord, Aprepitant Sandoz
- Portugal · Aprepitant Generis
- Sweden · Aprepitant Medical Valley, Aprepitant Stada
- Slovenia · Aprepitant Teva
- Slovakia · Aprepitant, Aprepitant Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9e22c517-a8fe-4c19-babd-6f28ce8aacdd GET /v1/drugs/9e22c517-a8fe-4c19-babd-6f28ce8aacdd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Aprepitant",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about aprepitant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.